The size of the Chromatography Instrumentation market in Europe has been estimated at USD 2.14 Billion in 2022 and is projected to reach USD 2.78 Billion by 2027. This market is estimated to project a CAGR of 5.40% from 2022 to 2027.
Rising funds of EU governments on R &D, growth in the pharmaceutical and biotechnology industries, and augmenting demand for the chromatography instruments for different research purposes are estimated to fuel the chromatography instrumentation market in Europe. The rise in the proteomics and genomics, well-organized healthcare systems, and advancements in the technology are further expected to boost the market. Regular FDA approvals for the key players' instruments and increasing adoption rates are also estimated to add fuel to the market.
The shortage of experienced and skilled professionals and alternative analytical technologies are expected to hamper the market growth to a small extent. Moreover, the high costs related to the chromatography instruments are one such factor impeding the transition.
This research report on the European Chromatography Instrumentation Market has been segmented and sub-segmented into the following categories:
Europe is the second biggest market in terms of market share across the globe. The market in Europe is highly driven due to factors like increasing research to develop new and innovative drugs.
The UK and German markets are expected to dominate the European market during the forecast period. Growing significance for food safety, increasing expenditure on pharmaceutical research and development activities, government policies, and other private bodies to reduce pollution in the environment, causing hazardous life in humans, is primarily accelerating the markets in these two countries.
France, Spain, Italy are predicted to have decent growth in the chromatography instrumentation market during the forecast period.
Notable companies leading the Europe Chromatography Instrumentation market profiled in this report are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Agilent Technologies, Shimadzu Corporation, Novasep Holding S.A.S., Waters Corporation, Pall Corporation, JASCO, Inc, Phenomenex, Inc., GE Healthcare, GL Sciences, Inc., Becton, Dickinson and Company, Pall Corporation, Regis Technologies, Life Technologies Corporation, Sigma-Aldrich Corporation, Phenomenex, Inc., Helena Laboratories and Tosoh Corporation.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com